| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/01/2011 | CN101475599B Novel method for synthesizing antineoplastic medicament nedaplatin |
| 06/01/2011 | CN101381402B NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 06/01/2011 | CN101361732B Medicinal preparation containing garcinia acid and use thereof |
| 06/01/2011 | CN101353361B Preparation of adriablastina prodrug and use thereof |
| 06/01/2011 | CN101348521B Aminoacid mimic epitope of human B lymphocyte stimulating factor receptor and use thereof |
| 06/01/2011 | CN101343328B Target-specificity dual-mutant amalgamation protein |
| 06/01/2011 | CN101338302B Recombination herpes simplex virus for tumor gene therapy |
| 06/01/2011 | CN101302235B Purification of picoplatin |
| 06/01/2011 | CN101230334B Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 06/01/2011 | CN101225049B Beta-elemene amino acid derivatives as well as synthetic method and use thereof |
| 06/01/2011 | CN101180293B Naphthalamide derivatives having antiproliferative activity |
| 06/01/2011 | CN101100681B Stemmacantha uniflora enzymolysis liquid and its preparing process and application |
| 06/01/2011 | CN101070300B Linonene anologs and its preparing method and use |
| 06/01/2011 | CN101011559B Traditional Chinese medicine preparation for treating malignant tumor and its preparation method |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
| 05/31/2011 | US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes |
| 05/31/2011 | US7951801 Beta-carbolines useful for treating inflammatory disease |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | US7951787 Phosphoramidate compounds and methods of use |
| 05/31/2011 | US7951780 Antitumor agent |
| 05/31/2011 | US7951778 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/31/2011 | US7951772 Tumor-activated prodrug compounds and treatment |
| 05/31/2011 | US7951585 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951395 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions |
| 05/31/2011 | US7951380 Methods of stimulating bone growth using ZVEGF4 polypeptides |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951366 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 05/31/2011 | US7951356 Tissue factor compositions and kits for coagulation and tumor treatment |
| 05/31/2011 | CA2583217C 1,3,4-thiadiazole compounds as protein kinase inhibitors |
| 05/31/2011 | CA2555745C Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 05/31/2011 | CA2497450C Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 05/31/2011 | CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/31/2011 | CA2430692C Geldanamycin derivative and use of same to treat cancer |
| 05/31/2011 | CA2412501C Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/31/2011 | CA2353822C Camptothecin analogs and methods of preparation thereof |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/27/2011 | CA2686587A1 Combination therapy for treating proliferative diseases |
| 05/26/2011 | WO2011063382A1 Materials and methods useful for affecting tumor cell growth, migration and invasion |
| 05/26/2011 | WO2011063336A2 Secondary site of antigen stimulation for therapeutic vaccination |
| 05/26/2011 | WO2011063241A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 05/26/2011 | WO2011063178A2 Intravenous infusion of curcumin and a calcium channel blocker |
| 05/26/2011 | WO2011063158A1 Salt form of a multi-arm polymer-drug conjugate |
| 05/26/2011 | WO2011063156A2 Acid salt forms of polymer-drug conjugates and alkoxylation methods |
| 05/26/2011 | WO2011062939A1 Methods and compositions for treating solid tumors and other malignancies |
| 05/26/2011 | WO2011062927A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity |
| 05/26/2011 | WO2011062909A2 Creating bioengineered lymph nodes |
| 05/26/2011 | WO2011062786A2 Compounds and methods for inhibiting the metastasis of cancer cells |
| 05/26/2011 | WO2011062592A2 Ds-1/la vie |
| 05/26/2011 | WO2011062503A1 Parenteral formulations of gemcitabine derivatives |
| 05/26/2011 | WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same |
| 05/26/2011 | WO2011062420A2 Nanoparticles for tumor-targeting and processes for the preparation thereof |
| 05/26/2011 | WO2011062372A2 2, 4, 7 -substituted thieno [3, 2 -d] pyrimidine compounds as protein kinase inhibitors |
| 05/26/2011 | WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region |
| 05/26/2011 | WO2011061666A1 Macrocyclic lactone derivatives for the treatment of cancer |
| 05/26/2011 | WO2011061613A1 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib |
| 05/26/2011 | WO2011061458A1 Pyridine-pyridinone derivatives, preparation and therapeutic use thereof |
| 05/26/2011 | WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 05/26/2011 | WO2011061236A1 Pharmaceutical compositions comprising an lrp1 receptor agonist for the treatment of cancer and hiv |
| 05/26/2011 | WO2011061222A1 Therapeutic combination comprising a cdc7 inhibitor and an antineoplastic agent |
| 05/26/2011 | WO2011061157A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof |
| 05/26/2011 | WO2011061154A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 05/26/2011 | WO2011061139A1 Substituted pyrrolidine-2-carboxamides |
| 05/26/2011 | WO2011060873A1 Quinazoline derivatives |
| 05/26/2011 | WO2011060746A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 05/26/2011 | WO2011060634A1 23-hydroxy-betulinic acid derivatives, preparation methods and uses thereof |
| 05/26/2011 | WO2011042797A4 Pyrazole derivatives as modulators of calcium release -activated calcium channel |
| 05/26/2011 | WO2011039308A3 Gluten-free foodstuff |
| 05/26/2011 | WO2011038924A3 Proteasome inhibitors for treating cancer |
| 05/26/2011 | WO2011014872A3 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 05/26/2011 | WO2011011692A3 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle) |
| 05/26/2011 | WO2011011186A3 Hdac inhibitors and therapeutic methods using the same |
| 05/26/2011 | WO2011005714A3 Bendamustine liposomal compositions |
| 05/26/2011 | WO2011005380A3 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 05/26/2011 | WO2010143188A3 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms |
| 05/26/2011 | WO2010120541A3 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/26/2011 | WO2010053600A3 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110124741 Radiosensitizer compositions comprising schisandra chinensis(turcz.)baill and methods for use |
| 05/26/2011 | US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors |
| 05/26/2011 | US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124710 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 05/26/2011 | US20110124709 Rna antagonists targeting gli2 |
| 05/26/2011 | US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process |
| 05/26/2011 | US20110124701 Use of hdac inhibitors for the treatment of lymphomas |
| 05/26/2011 | US20110124700 Systems and methods of cancer staging and treatment |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124692 Crystalline forms of thiazolidinedione compound and its manufacturing method |